Cerevel Therapeutics Hldg Inc (CERE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 11-2014 | 08-2014 | 05-2014 | 02-2014 | 11-2013 | |
| Sales | 400 | 340 | 806 | 495 | 763 |
| Cost of Goods | 442 | 581 | 575 | 556 | 1,309 |
| Gross Profit | -42 | -241 | 231 | -61 | -546 |
| Operating Expenses | 6,387 | 6,446 | 8,521 | 7,711 | 7,983 |
| Operating Income | -5,987 | -6,106 | -7,715 | -7,216 | -8,220 |
| Interest Expense | 3 | 24 | 25 | 19 | 0 |
| Other Income | 18 | -34 | 13 | 10 | 16 |
| Pre-tax Income | -5,972 | -6,164 | -7,727 | -7,225 | -8,204 |
| Income Tax | -1 | N/A | N/A | N/A | 1 |
| Net Income Continuous | -5,971 | -6,164 | -7,727 | -7,225 | -8,205 |
| Net Income | $-5,971 | $-6,164 | $-7,727 | $-7,225 | $-8,205 |
| EPS Basic Total Ops | -0.96 | 15.83 | -1.35 | -18.32 | -2.64 |
| EPS Basic Continuous Ops | -0.99 | 15.82 | -1.35 | -18.34 | -2.61 |
| EPS Diluted Total Ops | -0.96 | 15.83 | -1.35 | -18.32 | -2.64 |
| EPS Diluted Continuous Ops | -0.99 | 15.82 | -1.35 | -18.34 | -2.61 |
| EPS Diluted Before Non-Recurring Items | -0.96 | -0.72 | N/A | N/A | N/A |
| EBITDA(a) | $-5,798 | $-5,780 | $-7,333 | $-6,821 | $-7,806 |